Login / Signup

Once-weekly semaglutide use in patients with type 2 diabetes: real-world data from the SURE Italy observational study.

Raffaele NapoliCesare BerraAndrei-Mircea CatarigChiara Di LoretoEmily DonatielloTina Landsvig BerentzenDario PitoccoFrancesco Giorgino
Published in: Diabetes, obesity & metabolism (2023)
, BW and other outcomes. This article is protected by copyright. All rights reserved.
Keyphrases
  • electronic health record
  • big data
  • type diabetes
  • metabolic syndrome
  • data analysis
  • adipose tissue
  • deep learning
  • insulin resistance